Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Loratadine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1334810A reveals a safer phosphonate-based process for loratadine intermediates, eliminating toxic byproducts and improving supply chain stability for API manufacturing.
Analyzing patent CN113004245A for a mild, high-yield desloratadine preparation method offering significant cost reduction and improved purity for pharmaceutical manufacturing.
Novel patent CN115433123B offers safer loratadine intermediate synthesis. Eliminate hazardous reagents, ensure high purity, and optimize supply chain reliability for global pharmaceutical partners.